<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00617487</url>
  </required_header>
  <id_info>
    <org_study_id>EchostressSSc</org_study_id>
    <nct_id>NCT00617487</nct_id>
  </id_info>
  <brief_title>Pulmonary Arterial Hypertension in Systemic Sclerosis</brief_title>
  <official_title>Stress Echocardiography in the Early Identification of Pulmonary Arterial Hypertension in Systemic Sclerosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>IRCCS Policlinico S. Matteo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>IRCCS Policlinico S. Matteo</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the role of stress echocardiography, compared to
      standard echocardiography in the early identification of pulmonary arterial hypertension in
      systemic sclerosis. To evaluate the role of BNP in this setting.To analyze data recorded with
      respect to the parameters commonly used for SSc evaluation (eg thorax HRCT, pulmonary
      function tests + DLCO, nailfold capillaroscopy, etc); these parameters are available starting
      for 1999.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>December 2007</start_date>
  <completion_date type="Anticipated">January 2020</completion_date>
  <primary_completion_date type="Anticipated">March 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Systemic Sclerosis</condition>
  <condition>Pulmonary Arterial Hypertension</condition>
  <eligibility>
    <study_pop>
      <textblock>
        patients with systemic sclerosis
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with systemic sclerosis according to LeRoy criteria

        Exclusion Criteria:

          -  Pregnancy

          -  Significant valvular disease

          -  Low left ventricular function upon echocardiography (ejection fraction&lt;55%)

          -  History of atrial fibrillation, myocardial infarction, pulmonary thromboembolisms,
             neoplasia or severe hepatic disease.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stefano Ghio, MD</last_name>
    <role>Study Director</role>
    <affiliation>IRCCS Foundation Policlinico S. Matteo, Cardiology</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lorenzo Cavagna, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University and IRCCS Foundation Policlinico S. Matteo, Rheumatology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>IRCCS Foundation Policlinico S. Matteo</name>
      <address>
        <city>Pavia</city>
        <state>PV</state>
        <zip>27100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>IRCCS Policlinico S. Matteo</name>
      <address>
        <city>Pavia</city>
        <state>PV</state>
        <zip>27100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 6, 2008</study_first_submitted>
  <study_first_submitted_qc>February 15, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 18, 2008</study_first_posted>
  <last_update_submitted>March 6, 2018</last_update_submitted>
  <last_update_submitted_qc>March 6, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 7, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>IRCCS Policlinico S. Matteo</investigator_affiliation>
    <investigator_full_name>Carlomaurizio Montecucco</investigator_full_name>
    <investigator_title>Director, Dept. of Rheumatology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Sclerosis</mesh_term>
    <mesh_term>Familial Primary Pulmonary Hypertension</mesh_term>
    <mesh_term>Scleroderma, Systemic</mesh_term>
    <mesh_term>Scleroderma, Diffuse</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

